Neuren Pharmaceuticals Limited (ASX: NEU)

Neuren Pharmaceuticals Revenue

Neuren Pharmaceuticals had revenue of 24.33M AUD in the half year ending June 30, 2024. This brings the company's revenue in the last twelve months to 193.34M, up 146.79% year-over-year. In the year 2023, Neuren Pharmaceuticals had annual revenue of 231.94M with 1,404.46% growth.

• Revenue (ttm): 193.34M
• Revenue Growth: +146.79%
• P/S Ratio: 8.06
• Revenue / Employee: 24.17M
• Employees: 8
• Market Cap: 1.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	231.94M	216.53M	1,404.46%
Dec 31, 2022	15.42M	12.22M	382.23%
Dec 31, 2021	3.20M	2.48M	345.89%
Dec 31, 2020	717.00K	222.00K	44.85%
Dec 31, 2019	495.00K	-13.50M	-96.46%